Syndesi Therapeutics announces appointment of Roy Twyman MD to its Board of Directors
29.10.2018

Click to read the publication: 2018 10-SyndesiTherapeutics_PR_RTDirector_EN

A-MANSIA : 18 M€ and a high potential in the microbiote
02.10.2018

After a first closing at 13 M€ in April 2018, …

Continue reading

Emolytics
12.09.2018

Emolytics is a spin-off company of the Catholic University of …

Continue reading

Proximus, VIVES II and SRIW participate in a €3 million funding round in Tessares
29.03.2018

Proximus, VIVES II and SRIW participate in a €3 million …

Continue reading

NOVADIP announces …

NOVADIP announces … Click for more details    

More news